| Product NDC: | 49808-123 |
| Proprietary Name: | Podofilox |
| Non Proprietary Name: | PODOFILOX |
| Active Ingredient(s): | 5 mg/mL & nbsp; PODOFILOX |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49808-123 |
| Labeler Name: | Metacon Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090184 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100721 |
| Package NDC: | 49808-123-35 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (49808-123-35) > 3.5 mL in 1 BOTTLE, GLASS |
| NDC Code | 49808-123-35 |
| Proprietary Name | Podofilox |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (49808-123-35) > 3.5 mL in 1 BOTTLE, GLASS |
| Product NDC | 49808-123 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PODOFILOX |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20100721 |
| Marketing Category Name | ANDA |
| Labeler Name | Metacon Labs |
| Substance Name | PODOFILOX |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Mitosis [PE] |